Researcher Profile Form First National Pediatric Brain Tumor Research Meeting March 9, 2025 - Jerusalem
Researcher: Dr. Lana Volokh
Current Role & Affiliation
Title/Position: Co-founder & CEO, Director of AnserBio
Email: lanav@exoprother.com
Phone: 054-4236593
Lana Volokh is co-founder and CEO of AnserBio, an Israeli preclinical stage startup developing nano-particle based p53 replacement therapy.
The proprietary nano-particles have been shown to reach the brain through nasal inhalation and have potential to provide a unique treatment option for brain cancer patients
Research Focus
● Healthcare R&D and system engineering
● Clinical research and regulatory strategy
● Industry-academia collaborations
● Technology integration in clinical applications
Current Projects Related to Pediatric Brain Tumors
● Development of advanced healthcare technologies
● Strategic collaborations for clinical advancements
Professional Contributions
● Co-inventor on multiple patents
● Executive roles in startups like Arineta, Applied Spectral Imaging, and Theranica
Collaboration Interests
● Industry-academia partnerships
● Regulatory strategy for healthcare technologies
What You Can Offer Potential Collaborators
● Expertise in product development and market access
● Strategic insights for regulatory and clinical integration
Keywords
Healthcare Innovation, Clinical Research, System Engineering, Regulatory Strategy
Brief Bio
Dr. Lana Volokh is a seasoned healthcare scientist and executive with over two decades of experience in R&D, clinical research, and regulatory strategy. Her extensive background spans roles at GE Healthcare, Johns Hopkins University, and various innovative startups. Dr. Volokh's work focuses on developing products that integrate advanced technology with clinical applications.
